Want to see FR:FII full AI Analyst Report?
FII Stock Chart & Stats
€62.10
-€0.10(-0.43%)
At close: 4:00 PM EST
€62.10
-€0.10(-0.43%)
Day’s Range― - ―
52-Week Range€36.20 - €72.60
Previous CloseN/A
Volume691.00
Average Volume (3M)33.39K
Market Cap
€2.97B
Enterprise Value€3.32B
Total Cash (Recent Filing)€270.44M
Total Debt (Recent Filing)€504.16M
Price to Earnings (P/E)21.4
Beta0.93
Next Earnings
Jul 23, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.74%
Share Statistics
EPS (TTM)3.06
Shares Outstanding46,538,315
10 Day Avg. Volume24,786
30 Day Avg. Volume33,391
Financial Highlights & Ratios
PEG Ratio0.12
Price to Book (P/B)2.23
Price to Sales (P/S)1.39
P/FCF Ratio32.76
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€66.00Price Target Upside6.28% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)2.71
Revenue Forecast (FY)€1.93B
Bulls Say, Bears Say
Bulls Say
Durable B2B ModelLISI sells engineered fasteners and assemblies into long-lived aerospace platforms and series-production automotive programs. Those contract- and platform-driven revenues create multi-year demand visibility and customer lock-in from qualifications and certifications, supporting stable cash flows and execution over the next several quarters.
Improved LeverageNet debt reduced to under 50% of equity in 2025, giving the company greater financial flexibility. Lower leverage cuts refinancing and covenant risk, allows disciplined capex or targeted investments, and increases resilience to cyclical downturns in aerospace and auto markets over the medium term.
Positive Profitability And ReturnsAfter earlier losses, LISI returned to solid operating and net profitability with ROE near 13%. Persistent positive margins and respectable ROE indicate the business can generate returns above cost of capital, enabling reinvestment in processes and quality certifications that sustain competitive position across cycles.
Bears Say
Revenue SetbackA material revenue decline in 2025 interrupts prior growth momentum and signals demand or order-volatility in key end markets. Reduced top-line pressures operating leverage, heightens the need for cost control, and can erode margins and cash generation if volumes do not recover sustainably.
Moderate Cash ConversionFree cash flow is positive but consistently below half of reported earnings and fell in 2025. Persistent working-capital or investment absorption limits internal funding for capex, dividends or deleveraging, increasing reliance on financial flexibility and reducing buffer against earnings shocks.
Margin VolatilitySignificant year-to-year swings in gross and operating margins undermine earnings predictability. In cyclical aerospace and automotive markets, margin volatility raises execution risk, complicates pricing and cost planning, and can quickly pressure leverage and ROE if adverse market shifts persist.
Lisi SA News
FII FAQ
What was Lisi SA’s price range in the past 12 months?
Lisi SA lowest stock price was €36.20 and its highest was €72.60 in the past 12 months.
What is Lisi SA’s market cap?
Lisi SA’s market cap is €2.97B.
When is Lisi SA’s upcoming earnings report date?
Lisi SA’s upcoming earnings report date is Jul 23, 2026 which is in 9 days.
How were Lisi SA’s earnings last quarter?
Lisi SA released its earnings results on Feb 26, 2026. The company reported €0.87 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Lisi SA overvalued?
According to Wall Street analysts Lisi SA’s price is currently Undervalued.
Does Lisi SA pay dividends?
Lisi SA pays a Annually dividend of €0.46 which represents an annual dividend yield of 0.74%. See more information on Lisi SA dividends here
What is Lisi SA’s EPS estimate?
Lisi SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lisi SA have?
Lisi SA has 46,538,315 shares outstanding.
What happened to Lisi SA’s price movement after its last earnings report?
Lisi SA reported an EPS of €0.87 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.418%.
Which hedge fund is a major shareholder of Lisi SA?
Currently, no hedge funds are holding shares in FR:FII
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Lisi SA
Lisi S.A. is a global provider of specialized assembly and component solutions, primarily serving the aerospace, automotive, and medical sectors. The company organizes its operations into three distinct divisions: LISI Aerospace, LISI Automotive, and LISI Medical. LISI Aerospace specializes in advanced aircraft components, including titanium fasteners, lightning protection, safety locking mechanisms, and fuse pins. Their contributions to the LEAP engine encompass compressor blades, struts, and composite fan blade leading edges. They also produce air intake lipskins for Airbus aircraft, semi-machined gears for power transmission, stator vanes, and satellite antenna mounting brackets for both airplanes and helicopters. LISI Automotive delivers a broad spectrum of fastening and component solutions for vehicles. This includes guide pins, electric parking brake elements, complete braking systems, and direct engine injection parts. They supply various fasteners like screws, nuts, and specialized clips for interior and exterior trim, alongside components for seat belt mechanisms, motor systems, and safety applications. The division also focuses on assembly optimization, offering cable ducts, battery fastening systems, intricate power transmission parts, and standard automotive fasteners. Furthermore, they provide clipped fastening solutions for both internal and external cladding, specialized fasteners for tubes and cables, and products designed to reduce weight and streamline assembly processes. Their portfolio extends to critical components for braking, fluid management, seat adjustment, and interior safety systems. LISI Medical is involved in the complete lifecycle of medical device development, from initial design and modeling through prototyping, pre-series production, material selection, process validation, and inventory management. They manufacture a range of orthopedic reconstruction implants for shoulders, hips, knees, and extremities, along with associated surgical instruments. The division also produces various surgical tools, such as blades, scissors, staplers, and pliers. Additionally, they provide spinal and trauma implants, including connectors, screws, cages, plates, and prostheses, specifically designed for treating trauma and facilitating osteosynthesis. Established in 1777, the company, originally known as GFI Industries, adopted the name LISI S.A. in 2002. Headquartered in Belfort, France, it operates as a subsidiary of Compagnie Industrielle De Delle S.A.
FII Stock 12 Month Forecast
Average Price Target
€66.00
▲(6.28% Upside)
Technical Analysis
Options Prices
Currently, No data available
---





